智擎生技製藥股份有限公司
今日上漲 2.83%,股價站回短期均線。該股 RSI(6) 為 53.9,處於中性區間,短線無明顯超買超賣訊號。股價站上5日均線,跌破20日、60日、120日均線。短中期均線呈空頭排列,趨勢偏空。KD 指標中性(K=43.7);MACD 柱狀體為負值,空方動能持續。 (自動產生 · 非投資建議)
智擎生技製藥股份有限公司(PharmaEngine, Inc.)在台灣從事癌症治療藥物的開發。其產品「ONIVYDE(安能得)」用於治療胰腺癌。目前正開發 PEP07(CHK1 抑制劑)用於血液腫瘤與實體瘤的臨床研究。公司成立於 2002 年,總部位於台灣台北。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 11-13 | +49 | 0 | -4 | +45 |
| 11-12 | +75 | 0 | +2 | +77 |
| 11-11 | -63 | +30 | -2 | -35 |
| 11-10 | +73 | 0 | -12 | +61 |
| 11-09 | -139 | +30 | +3 | -106 |
| 11-06 | +218 | +30 | 0 | +248 |
| 11-05 | -15 | 0 | -9 | -24 |
| 11-04 | -7 | 0 | +6 | -1 |
| 11-03 | +39 | 0 | -3 | +37 |
| 11-02 | -84 | 0 | -7 | -90 |
| 10-30 | +101 | 0 | -23 | +78 |
| 10-29 | +85 | 0 | +2 | +87 |
| 10-28 | +22 | 0 | +10 | +32 |
| 10-27 | -25 | 0 | +21 | -4 |
| 10-22 | +25 | 0 | +28 | +53 |
| 10-21 | -13 | 0 | +27 | +14 |
| 10-20 | -5 | 0 | +4 | -1 |
| 10-19 | -39 | 0 | -1 | -40 |
| 10-16 | +92 | 0 | +12 | +104 |
| 10-15 | +133 | 0 | -12 | +121 |
| 10-14 | -4 | 0 | -1 | -4 |
| 10-13 | -46 | 0 | +16 | -30 |
| 10-12 | -15 | 0 | 0 | -15 |
| 10-08 | -121 | 0 | 0 | -121 |
| 10-07 | +25 | 0 | 0 | +25 |
| 10-06 | +22 | 0 | 0 | +22 |
| 10-05 | -59 | 0 | -2 | -61 |
| 10-02 | -7 | 0 | 0 | -7 |
| 10-01 | -55 | 0 | -3 | -58 |
| 09-30 | +56 | 0 | 0 | +56 |
| 09-29 | -33 | 0 | -1 | -34 |
| 09-24 | -76 | 0 | 0 | -76 |
| 09-23 | +92 | 0 | +2 | +94 |
| 09-22 | +62 | 0 | +2 | +65 |
| 09-21 | -10 | 0 | +4 | -6 |
| 09-18 | -42 | 0 | -1 | -43 |
| 09-17 | +169 | 0 | +6 | +175 |
| 09-16 | -18 | 0 | +4 | -14 |
| 09-15 | +12 | 0 | +3 | +15 |
| 09-14 | -15 | 0 | -1 | -16 |
| 09-11 | +5 | 0 | 0 | +5 |
| 09-10 | -70 | 0 | -1 | -71 |
| 09-09 | -46 | 0 | 0 | -46 |
| 09-08 | +36 | 0 | 0 | +36 |
| 09-07 | -45 | 0 | -1 | -46 |
| 09-04 | +14 | 0 | 0 | +14 |
| 09-03 | +55 | 0 | +1 | +56 |
| 09-02 | +110 | 0 | -1 | +109 |
| 09-01 | -71 | 0 | 0 | -71 |
| 08-31 | -60 | 0 | 0 | -60 |
| 08-28 | -42 | +60 | +1 | +19 |
| 08-27 | +54 | 0 | +5 | +60 |
| 08-26 | +88 | 0 | -1 | +87 |
| 08-25 | +3 | 0 | -1 | +2 |
| 08-24 | -57 | 0 | -10 | -67 |
| 08-21 | +60 | 0 | 0 | +60 |
| 08-20 | +141 | 0 | -4 | +137 |
| 08-19 | -43 | 0 | -30 | -73 |
| 08-18 | +35 | 0 | -1 | +34 |
| 08-17 | -161 | 0 | +6 | -155 |
| 08-14 | -66 | 0 | -4 | -70 |
| 08-13 | +149 | 0 | +1 | +150 |
| 08-12 | +142 | 0 | -3 | +139 |
| 08-11 | -54 | 0 | -4 | -58 |
| 08-10 | +213 | 0 | -2 | +211 |
| 08-07 | +178 | 0 | +3 | +181 |
| 08-06 | -7 | 0 | -1 | -8 |
| 08-05 | -79 | 0 | 0 | -79 |
| 08-04 | +30 | 0 | 0 | +30 |
| 08-03 | +67 | 0 | -1 | +66 |
| 07-31 | -194 | 0 | 0 | -194 |
| 07-30 | +145 | 0 | +3 | +148 |
| 07-29 | +224 | 0 | -3 | +221 |
| 07-28 | +137 | 0 | -1 | +136 |
| 07-27 | -3 | 0 | 0 | -3 |
| 07-24 | +55 | 0 | -2 | +53 |
| 07-23 | -209 | +100 | -2 | -111 |
| 07-22 | +117 | 0 | -1 | +116 |
| 07-21 | +54 | 0 | +5 | +59 |
| 07-20 | +98 | 0 | +8 | +107 |
| 07-17 | +25 | 0 | -9 | +16 |
| 07-16 | -296 | 0 | +3 | -293 |
| 07-15 | +257 | 0 | +24 | +281 |
| 07-14 | +47 | 0 | -1 | +46 |
| 07-13 | +287 | 0 | -2 | +285 |
| 07-09 | +302 | 0 | +3 | +305 |
| 07-08 | -183 | +100 | +2 | -81 |
| 07-07 | +194 | 0 | -1 | +194 |
| 07-06 | -53 | 0 | +2 | -51 |
| 07-03 | +281 | 0 | +6 | +287 |
| 07-02 | -332 | 0 | -6 | -338 |
| 07-01 | +244 | 0 | +1 | +245 |
| 06-30 | +247 | 0 | +3 | +250 |
| 06-29 | +92 | 0 | +4 | +96 |
| 06-26 | +43 | 0 | +1 | +45 |
| 06-25 | -68 | 0 | 0 | -68 |
| 06-24 | +228 | 0 | +7 | +235 |
| 06-23 | +207 | 0 | +4 | +210 |
| 06-22 | -29 | 0 | 0 | -29 |
| 06-18 | +40 | 0 | 0 | +40 |
| 06-17 | -37 | 0 | -4 | -41 |
| 06-16 | -18 | 0 | +1 | -17 |
| 06-15 | -26 | 0 | 0 | -26 |
| 06-12 | +126 | 0 | -4 | +121 |
| 06-11 | -150 | 0 | +3 | -147 |
| 06-10 | +47 | 0 | +5 | +52 |
| 06-09 | +52 | 0 | -1 | +51 |
| 06-08 | +199 | 0 | +1 | +199 |
| 06-05 | +196 | 0 | +1 | +197 |
| 06-04 | +21 | 0 | -41 | -20 |
| 06-03 | -128 | 0 | 0 | -128 |
| 06-02 | +118 | 0 | +2 | +120 |
| 06-01 | +169 | 0 | -4 | +165 |
| 05-29 | +273 | 0 | -1 | +272 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 2253 萬 | -89.9% | -18.3% |
| 2026/09 | 2.23 億 | +982.1% | +13.1% |
| 2026/08 | 2065 萬 | -11.5% | -7.0% |
| 2026/07 | 2334 萬 | -88.7% | +4.4% |
| 2026/06 | 2.06 億 | +631.2% | +33.9% |
| 2026/05 | 2815 萬 | +17.3% | +51.9% |
| 2026/04 | 2401 萬 | -84.5% | -2.1% |
| 2026/03 | 1.55 億 | +1080.9% | +6.0% |
| 2026/02 | 1308 萬 | -81.9% | -28.1% |
| 2026/01 | 7219 萬 | -68.3% | +208.3% |
| 2025/12 | 2.27 億 | +657.6% | -87.6% |
| 2025/11 | 3003 萬 | - | +29.9% |